XTL Biopharma (XTLB) Reports Q2 Loss of $0.002/Share

XTL Biopharma (NASDAQ: XTLB) reported Q2 EPS of $-0.002, versus $-0.001 reported last year.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.

You May Also Be Interested In

• Super Micro Computer (SMCI) Falls 6%
• Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14
• PayPal (PYPL) stock: Risk-reward 'finally looks favorable' says Deutsche Bank